TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,000 | -10.0% | 1,291 | -9.3% | 0.00% | 0.0% |
| Q1 2022 | $20,000 | +400.0% | 1,424 | +376.3% | 0.00% | +300.0% |
| Q4 2021 | $4,000 | -85.7% | 299 | -82.5% | 0.00% | -80.0% |
| Q3 2021 | $28,000 | +3.7% | 1,707 | +5.0% | 0.01% | 0.0% |
| Q2 2021 | $27,000 | -18.2% | 1,625 | -10.9% | 0.01% | -37.5% |
| Q1 2021 | $33,000 | -57.1% | 1,823 | -57.0% | 0.01% | -57.9% |
| Q4 2020 | $77,000 | +185.2% | 4,240 | +181.4% | 0.02% | +111.1% |
| Q3 2020 | $27,000 | 0.0% | 1,507 | 0.0% | 0.01% | -10.0% |
| Q2 2020 | $27,000 | +68.8% | 1,507 | +41.8% | 0.01% | +42.9% |
| Q1 2020 | $16,000 | +77.8% | 1,063 | +135.2% | 0.01% | +133.3% |
| Q4 2019 | $9,000 | +12.5% | 452 | 0.0% | 0.00% | -25.0% |
| Q3 2019 | $8,000 | +14.3% | 452 | +8.7% | 0.00% | +33.3% |
| Q2 2019 | $7,000 | 0.0% | 416 | +25.7% | 0.00% | -25.0% |
| Q1 2019 | $7,000 | – | 331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |